How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies
Rémy Dumont, Etienne Lengliné, Clara Delorme, Jean-Pierre Bru, Sévérine Ansart, Elisabeth Aslangul, Sophie Kelley, Pierre Cochat, Sylvie Chevret, Thierno Diatta · 2024
Read How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies by Rémy Dumont, Etienne Lengliné, Clara Delorme, Jean-Pierre Bru, Sévérine Ansart, Elisabeth Aslangul, Sophie Kelley, Pierre Cochat, Sylvie Chevret, Thierno Diatta (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11703620.txt.
Description
Remy Dumont and co-authors compare how three European agencies judged new antibiotics in the fight against drug-proof bacteria. Making new antibiotics pays poorly, so clear public rulings could spur drug makers. The study lines up French rulings beside German and English ones across five years.
France's committee found clinical benefit in all fifteen uses it judged. It granted added value in nine and public health interest in eight. Five prized drugs were tagged for reserve use, held back to slow resistance. Only eight drugs could be matched across all three systems. Germany and England also parked several in reserve status. Three drugs landed in the same spot everywhere. The authors argue that open, aligned rulings can reward firms that tackle resistance.
Catalog record
| CREATOR | Rémy Dumont, Etienne Lengliné, Clara Delorme, Jean-Pierre Bru, Sévérine Ansart, Elisabeth Aslangul, Sophie Kelley, Pierre Cochat, Sylvie Chevret, Thierno Diatta |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |